While overseas acquisitions by Chinese buyers are cooling after two record years, deals into the country are on the rise, with new rules making it easier for foreign direct investment
In the news: China kicks off 2017 with strong inbound M&A, a push to simplify the national drug distribution network and develop its own digital currency
FDI deals so far in 2017 have almost doubled on year to $7.1 billion, the State Council said it would more than halve the number of drug distributors to cut pharmaceutical prices, and the PBOC has run trials of its new cryptocurrency
By
Katherine Jo
& clp articles